Colchicine as an adjunct to heparin for prophylaxis of venous thromboembolism in patients with COVID-19
Author:
Publisher
Springer Science and Business Media LLC
Subject
Immunology,Immunology and Allergy,Rheumatology
Link
http://link.springer.com/content/pdf/10.1007/s00296-020-04753-8.pdf
Reference9 articles.
1. Misra DP, Gasparyan AY, Zimba O (2020) Benefits and adverse effects of hydroxychloroquine, methotrexate and colchicine: searching for repurposable drug candidates. RheumatolInt 40(11):1741–1751
2. Busch MH, Timmermans S, Nagy M et al (2020) Neutrophils and contact activation of coagulation as potential drivers of COVID-19. Circulation 142(18):1787–1790
3. Middleton EA, He XY, Denorme F et al (2020) Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome. Blood 136(10):1169–1179
4. Hasan SS, Radford S, Kow CS, Zaidi STR (2020) Venous thromboembolism in critically ill COVID-19 patients receiving prophylactic or therapeutic anticoagulation: a systematic review and meta-analysis. J Thromb Thrombolysis 50(4):814–821
5. Musoke N, Lo KB, Albano J et al (2020) Anticoagulation and bleeding risk in patients with COVID-19. Thromb Res 196:227–230 (published online ahead of print, 2020 Aug 24)
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Anakinra for the prophylaxis of venous thromboembolism in patients with COVID-19;Inflammopharmacology;2023-04-10
2. Role of colchicine in the management of COVID-19 patients: A meta-analysis of cohort and randomized controlled trials;Clinical Epidemiology and Global Health;2022-07
3. Metformin therapy in COVID-19: inhibition of NETosis;Journal of Thrombosis and Thrombolysis;2022-06-02
4. Therapeutic role of immunomodulators during the COVID-19 pandemic– a narrative review;Postgraduate Medicine;2022-02-12
5. Colchicine for COVID-19: Hype or hope?;European Journal of Internal Medicine;2021-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3